Document is current
Any future updates will be listed below
-
Authors
Kuna, Constantin
Bradaric, Christian
Schroeter, Mira
Presch, Antonia
Voll, Felix
Kufner, Sebastian
Ibrahim, Tareq
Schunkert, Heribert
Laugwitz, Karl-Ludwig
Cassese, Salvatore
Kastrati, Adnan
Wiebe, Jens https://orcid.org/0000-0003-4170-7347
-
Funding
Funding for this research was provided by:
Technische Universität München
- License Information
-
More Information
Article History
Received: 31 August 2024
Accepted: 8 January 2025
First Online: 3 February 2025
Declarations
:
: Constantin Kuna has received a speaker fee from AstraZeneca. Sebastian Kufner reports speaker and consulting fees from AstraZeneca, Bristol-Myers Squibb, and Bentley and speaker fees from Abbott, Boehringer-Ingelheim and Translumina and a research grant from Bentley, not related the current work. Heribert Schunkert has received lecture fees from AstraZeneca, Bayer Vital, Novartis, Servier, Sanofi-Aventis, Synlab, Bristol-Myers Squibb and Amarin, consulting fees from Amgen, AstraZeneca, Boehringer-Ingelheim, Daiichi-Sankyo and Servier and external funds from AstraZeneca, St. Jude and Boston Scientific. Jens Wiebe reports lecture fees from AstraZeneca, Translumina and Abbott Vascular and received Institutional Research Grant support from Abbott Vascular. The other authors have no relevant financial or non-financial interests to disclose.
